SCHEMBL10114719

SCHEMBL10114719

CC(=O)Oc1cc(Cl)c(C(=O)Nc2nc(S(C)(=O)=O)cs2)cc1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.39
RXFP1 Q9HBX9 1/20 0.39
GCK P35557 4/20 0.38
NPC1 O15118 7/20 0.38
RAB9A P51151 7/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
PYGL P06737 1/20 0.38
MITF O75030 1/20 0.38
PDE5A O76074 1/20 0.38
ALDH1A1 P00352 3/20 0.38
GAA P10253 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
MAPK1 P28482 1/20 0.38
HPGD P15428 3/20 0.37
TP53 P04637 1/20 0.37
HTT P42858 1/20 0.37
HSD17B10 Q99714 1/20 0.37
RCE1 Q9Y256 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10114672 0.92 MAPK1 (0.39) KDM4ERXFP1GCKNPC1RAB9A
SCHEMBL4757332 0.87 GCK (0.44) KDM4ERXFP1GCKNPC1RAB9A
SCHEMBL4757341 0.83 GPR27 (0.43) KDM4ERXFP1GCKNPC1RAB9A
SCHEMBL10114630 0.82 SCN9A (0.41) ABL1
SCHEMBL10114469 0.82 MAPK1 (0.42) KDM4EGCKNPC1RAB9ASMN1; SMN2
SCHEMBL703188 0.81 ALDH1A1 (0.50) KDM4EGCKNPC1RAB9ASMN1; SMN2
SCHEMBL4756811 0.81 NPC1 (0.38) GCKNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL10114430 0.81 RAB9A (0.50) KDM4EGCKNPC1RAB9ASMN1; SMN2
SCHEMBL12974190 0.81 GCK (0.41) KDM4ERXFP1GCKNPC1RAB9A
SCHEMBL10114656 0.81 RAB9A (0.44) KDM4EGCKNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2178852-B9 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LAB LC (US) 2016-06-22 EP disclosed
EP-2178852-B1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LAB LC (US) 2015-07-22 EP disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC KDM4E 2428/4885RXFP1 4741/4885GCK 1360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.